{"AllianceGenome": "9040", "HGNC": "9040", "MIM": "601690", "_id": "7941", "_version": 1, "accession": {"genomic": ["AL451143.15", "AL591242.4", "CH471081.1", "CP068272.2", "EF568110.1", "NC_000006.12", "NC_060930.1", "NG_016204.1"], "protein": ["AAB04170.1", "AAC50126.1", "AAH38452.1", "ABQ01234.1", "BAF83070.1", "BAG57699.1", "BAG59587.1", "EAX04301.1", "EAX04302.1", "NP_001161829.1", "NP_005075.3", "Q13093.1", "XP_005249465.1", "XP_047275315.1", "XP_047275316.1", "XP_054212394.1", "XP_054212395.1"], "rna": ["AK290381.1", "AK294471.1", "AK297066.1", "BC025674.1", "BC038452.1", "BP326231.1", "NM_001168357.2", "NM_005084.4", "U20157.1", "U24577.1", "XM_005249408.5", "XM_047419359.1", "XM_047419360.1", "XM_054356419.1", "XM_054356420.1"], "translation": [{"protein": "XP_054212395.1", "rna": "XM_054356420.1"}, {"protein": "AAB04170.1", "rna": "U24577.1"}, {"protein": "AAH38452.1", "rna": "BC038452.1"}, {"protein": "NP_001161829.1", "rna": "NM_001168357.2"}, {"protein": "XP_047275315.1", "rna": "XM_047419359.1"}, {"protein": "BAG59587.1", "rna": "AK297066.1"}, {"protein": "XP_054212394.1", "rna": "XM_054356419.1"}, {"protein": "XP_047275316.1", "rna": "XM_047419360.1"}, {"protein": "XP_005249465.1", "rna": "XM_005249408.5"}, {"protein": "NP_005075.3", "rna": "NM_005084.4"}, {"protein": "BAG57699.1", "rna": "AK294471.1"}, {"protein": "BAF83070.1", "rna": "AK290381.1"}, {"protein": "AAC50126.1", "rna": "U20157.1"}]}, "alias": ["LDL-PLA2", "LP-PLA2", "PAFAD", "PAFAH"], "ec": "3.1.1.47", "ensembl": {"gene": "ENSG00000146070", "protein": ["ENSP00000274793", "ENSP00000445666"], "transcript": ["ENST00000274793", "ENST00000537365"], "translation": [{"protein": "ENSP00000274793", "rna": "ENST00000274793"}, {"protein": "ENSP00000445666", "rna": "ENST00000537365"}], "type_of_gene": "protein_coding"}, "entrezgene": "7941", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 16.6365382428, "exp_mis": 122.67172552, "exp_syn": 46.2498986348, "lof_z": 0.15459046015969, "mis_z": -3.06164495565063, "mu_lof": 1.0765573049e-06, "mu_mis": 1.05425996795e-05, "mu_syn": 3.72866332771e-06, "n_lof": 16.0, "n_mis": 192.0, "n_syn": 48.0, "p_li": 8.02276784444073e-11, "p_null": 0.926240924060211, "p_rec": 0.0737590758595616, "syn_z": -0.159535352541608}, "bp": 1326, "cds_end": 46690628, "cds_start": 46672296, "n_exons": 11, "nonpsych": {"exp_lof": 14.8333587018, "exp_mis": 110.805438587, "exp_syn": 41.6363079161, "lof_z": 0.212502575402025, "mis_z": -3.21970119221482, "mu_lof": 1.0765573049e-06, "mu_mis": 1.05425996795e-05, "mu_syn": 3.72866332771e-06, "n_lof": 14.0, "n_mis": 178.0, "n_syn": 41.0, "p_li": 2.11669632815178e-09, "p_null": 0.876768479421795, "p_rec": 0.123231518461509, "syn_z": 0.062086350522753}, "nontcga": {"exp_lof": 15.283750909, "exp_mis": 112.836130929, "exp_syn": 42.5280439433, "lof_z": 0.0715984392653815, "mis_z": -3.15007893446364, "mu_lof": 1.0765573049e-06, "mu_mis": 1.05425996795e-05, "mu_syn": 3.72866332771e-06, "n_lof": 15.0, "n_mis": 180.0, "n_syn": 39.0, "p_li": 2.8853665243851e-10, "p_null": 0.918805090050977, "p_rec": 0.0811949096604862, "syn_z": 0.342545352640097}, "transcript": "ENST00000274793.7"}, "exons": [{"cdsend": 46722891, "cdsstart": 46704559, "chr": "6", "position": [[46704315, 46704696], [46705152, 46705301], [46707990, 46708161], [46709326, 46709418], [46710544, 46710658], [46711495, 46711619], [46712268, 46712337], [46714459, 46714553], [46716383, 46716528], [46716974, 46717096], [46722782, 46722925], [46735549, 46735693]], "strand": -1, "transcript": "NM_001168357", "txend": 46735693, "txstart": 46704315}, {"cdsend": 46722891, "cdsstart": 46704559, "chr": "6", "position": [[46704200, 46704696], [46705152, 46705301], [46707990, 46708161], [46709326, 46709418], [46710544, 46710658], [46711495, 46711619], [46712268, 46712337], [46714459, 46714553], [46716383, 46716528], [46716974, 46717096], [46722782, 46722925], [46735179, 46735375]], "strand": -1, "transcript": "NM_005084", "txend": 46735375, "txstart": 46704200}], "exons_hg19": [{"cdsend": 46690628, "cdsstart": 46672296, "chr": "6", "position": [[46672052, 46672433], [46672889, 46673038], [46675727, 46675898], [46677063, 46677155], [46678281, 46678395], [46679232, 46679356], [46680005, 46680074], [46682196, 46682290], [46684120, 46684265], [46684711, 46684833], [46690519, 46690662], [46703286, 46703430]], "strand": -1, "transcript": "NM_001168357", "txend": 46703430, "txstart": 46672052}, {"cdsend": 46690628, "cdsstart": 46672296, "chr": "6", "position": [[46671939, 46672433], [46672889, 46673038], [46675727, 46675898], [46677063, 46677155], [46678281, 46678395], [46679232, 46679356], [46680005, 46680074], [46682196, 46682290], [46684120, 46684265], [46684711, 46684833], [46690519, 46690662], [46702916, 46703112]], "strand": -1, "transcript": "NM_005084", "txend": 46703112, "txstart": 46671939}], "generif": [{"pubmed": 11248283, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 11369691, "text": "Overexpression of hPLA2G7 by adenoviral gene transfer in mice diminished the neointima formation (restenosis) induced by a wire-guided denudation of endothelium of the common left carotid and spontaneous atherosclerosis in aortic roots."}, {"pubmed": 11501940, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 11807372, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 11807372, "text": "The genetic mutation of plasma PAF-AH gene appear to be an independent risk factor for AAA (abdominal aortic aneurysm)"}, {"pubmed": 11810302, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 11850055, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 11861667, "text": "the ratio of HDL-associated PAF-AH-total plasma enzyme activity may be useful as a potential marker of atherogenicity in subjects with primary hypercholesterolemia."}, {"pubmed": 12068200, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12428682, "text": "electrotransfer of the human plasma PAF-AH gene to skeletal muscle reduces the extent of atherosclerosis in apoE(-/-) mice"}, {"pubmed": 12466264, "text": "role as oxidized phospholipid hydrolase of high density lipoprotein particles"}, {"pubmed": 12548211, "text": "colony-stimulating factors may modulate the local concentration of platelet-activating factor in the decidua via their inhibitory or stimulatory effect on the secretion of platelet-activating factor acetylhydrolase"}, {"pubmed": 12590019, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12649088, "text": "Human plasma PAF-AH exerts an antiatherogenic effect by binding to all the lipoproteins and thereby protecting them from oxidation, producing less proatherogenic lipoproteins and preserving HDL functions."}, {"pubmed": 12801611, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12801611, "text": "This genotype is not major determinant of population genetic risk of coronary heart disease(CHD), but association of this genotype with low levels of Lp-PLA(2) strongly support pro-inflammatory causative, and not consequential, role of Lp-PLA(2) in CHD."}, {"pubmed": 14671207, "text": "Platelet-activating factor inhibits PAF-AH secretion by decidual macrophages.Inhibitory action is mediated by signal transduction involving intracellular calcium and protein kinase C."}, {"pubmed": 15081260, "text": "The PAF-AH gene missense mutation has no relation to either susceptibility or severity of conventional multiple sclerosis, yet its activity is down-regulated, and it may confer the severity of female opticospinal-MS."}, {"pubmed": 15115767, "text": "Ala379 substitution to Val in PLA2G7 was less frequent in CAD patients than in controls, was associated with a lower risk of future CAD and showed higher plasma activity, thus Val379 may be protective against development of CAD."}, {"pubmed": 15115767, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15148590, "text": "mutations InsA191 and I317N impair function of the Lp-PLA2 gene in lipoprotein-associated phospholipase A2 deficiency patients"}, {"pubmed": 15215249, "text": "the mechanism by which LPS modulates expression of PAF AH at the transcriptional level"}, {"pubmed": 15318030, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15364890, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15956136, "text": "OxLDL accumulates in arteries in nonhyperlipidemic transgenic animals within 1 week after injury and local expression of human PAFAH reduces this accumulation and exerts antiinflammatory, antithrombotic, and antiproliferative effects"}, {"pubmed": 16086290, "text": "The findings show that the 994(G--> T) mutation of plasma PAF-AH gene may be an independent risk for atherosclerotic cerebral infarction, but not for lacunar infarction."}, {"pubmed": 16223884, "text": "lipoprotein-associated phospholipase A(2) activity, but not the enzyme mass, is a marker of small, dense LDL in human plasma"}, {"pubmed": 16308493, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16371369, "text": "PAF acetylhydrolases play key roles in the hydrolysis of F2-isoprostanes esterified on phospholipids in vivo"}, {"pubmed": 16438975, "text": "Lp-PLA2 activity and PLA2G7 A379V genotype were related to mediators of atherosclerosis in a diabetic study."}, {"pubmed": 16530769, "text": "Lipoprotein-associated phospholipase A(2) (Lp-PLA(2))is strongly correlated with several cardiovascular risk factors."}, {"pubmed": 16787988, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 17090529, "text": "PON1 is neither a PLOOH peroxidase nor hydrolase and that the phospholipase A(2)-like activity previously attributed to PON1 in natural enzyme preparations was actually due to novel PLOOH hydrolytic activity of contaminating PAF-AH"}, {"pubmed": 17092424, "text": "COX-2 and PAF-AH play a role in the occurrence of MODS"}, {"pubmed": 17160904, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 17174223, "text": "Lipoprotein-associated phospholipase A2 A379V variant is associated with body composition changes in response to exercise training."}, {"pubmed": 17174223, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 17251670, "text": "The distribution of platelet-activating factor acetylhydrolase (PAF-AH) was associated with paroxysmal atrial fibrillation (AF) and may be a marker of inflammation in patients with paroxysmal AF."}, {"pubmed": 17502572, "text": "Early coronary atherosclerosis in humans is characterized by local production of Lp-PLA2. Local coronary production of lysophosphatidylcholine, the active product of Lp-PLA2, is associated with endothelial dysfunction."}, {"pubmed": 17509958, "text": "The increased values of VEGF, PLA2-LDL and P-selectin in patients with long standing pulmonary hypertension are related to severe endothelial dysfunction and may have prognostic values."}, {"pubmed": 17587752, "text": "LDL-C level showed a significant interaction with the G994T genotype in Japanese"}, {"pubmed": 17908960, "text": "inactivation of PAF, produced by TEC, by the overexpression of plasma PAF-AH affects survival, migration, and the angiogenic response of TEC both in vitro and in vivo"}, {"pubmed": 17981297, "text": "PAF-AcH could play an anti-inflammatory role by reducing the concentration of PAF."}, {"pubmed": 18001304, "text": "We described two new highly polymorphic markers located 31 bp downstream of the last nucleotide of exon 12 in the 3' UTR region of the gene PLA2G7"}, {"pubmed": 18061193, "text": "Race and sex independently influence Lp-PLA2 activity and mass"}, {"pubmed": 18094516, "text": "Lp-PLA2 may have different mechanisms of action among American and Japanese men. Lp-PLA2 levels can not explain the observed CAC differences between the two populations."}, {"pubmed": 18165686, "text": "Electrospray ionization mass spectrometry identifies substrates and products of lipoprotein-associated phospholipase A2 in oxidized human low density lipoprotein"}, {"pubmed": 18201705, "text": "Elevated levels of Lp-PLA(2)(lipoprotein-associated phospholipase A2) activity and mass, respectively, were in this study, independently of established risk factors related to the incidence of ischemic stroke"}, {"pubmed": 18204052, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18204052, "text": "PLA2G7 represents an important, potentially functional candidate in the pathophysiology of coronary artery disease based on replicated associations using two independent datasets and multiple statistical approaches."}, {"pubmed": 18259035, "text": "Lp-PLA(2) was associated with incident ischemic stroke independently of C-reactive protein and traditional cardiovascular risk factors among nonusers of hormone therapy with highest risk in those who had both high C-reactive protein and high Lp-PLA(2)"}, {"pubmed": 18356547, "text": "These findings strongly support a role for Lp-PLA2 in the pathophysiology and clinical presentation of cerebrovascular disease."}, {"pubmed": 18383322, "text": "association of Lp-PLA(2) levels with arterial disease events implies a role for this enzyme in atherogenesis, our findings suggest that it is not prothrombotic."}, {"pubmed": 18408575, "text": "Lp-PLA2 is independently associated with progression of cardiac allograft vasculopathy and predicts a higher incidence of cardiovascular events and cardiovascular death in transplant patients"}, {"pubmed": 18431085, "text": "The aim of the present study was to evaluate the contribution of the PAFAH gene Arg92His, Ile198Thr and Ala379Val polymorphisms to resistance toward developing cardiovascular events in healthy Sicilian octogenarians."}, {"pubmed": 18434304, "text": "mouse and human PAF-AHs associate with human HDL particles of different density"}, {"pubmed": 18587071, "text": "In atherogenic aortas, an imbalance between PAF-AH and transacetylase activity, as well as lyso-PAF accumulation, may lead to unregulated PAF formation and to progression of atherosclerosis"}, {"pubmed": 18660489, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18779277, "text": "Association of elevated Lp-PLA(2) activity with coronary disease risk in relation to oxidant stress supports a proatherogenic role of Lp-PLA(2)."}, {"pubmed": 18784071, "text": "crystal structure is also presented of PAF acetylhydrolase reacted with the organophosphate compound paraoxon via its active site Ser273"}, {"pubmed": 18789441, "text": "Plasma lipoprotein-associated phospholipase A2 has a role in heart failure"}, {"pubmed": 18832472, "text": "If Lp-PLA(2) independently influences clinical events, it does so by promoting atherosclerotic plaque instability rather than by stimulating atherogenesis."}, {"pubmed": 18930040, "text": "Results describe the correlations between the plasma levels of adiponectin and two markers of inflammation: lipoprotein associated phospholipase A2 (Lp-PLA2) and myeloperoxidase (MPO)."}, {"pubmed": 18983494, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19034521, "text": "An independent association of increased plasma Lp-PLA(2) activity with coronary heart disease and myocardial infarction existed in this Chinese Han Population."}, {"pubmed": 19034521, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19069165, "text": "plasma PAF-AH deficiency may be considered as a genetic risk factor for stroke. (review)"}, {"pubmed": 19135199, "text": "Cardiovascular risk factors and genetic variation contribute to variability in Lp-PLA(2) activity and mass."}, {"pubmed": 19247692, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19272461, "text": "The potential role of Lp-PLA2 associated with different lipoprotein classes in atherosclerosis and cardiovascular disease, is discussed."}, {"pubmed": 19336475, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19359705, "text": "the relationship between Lp-PLA(2) and oxLDL in the atherosclerotic plaque"}, {"pubmed": 19373214, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19373214, "text": "The 994T allele increased the plasma oxLDL/LDL ratio in a recessive manner, whereas 994T had a codominant effect on the Lp-PLA(2) activity."}, {"pubmed": 19500354, "text": "Lp-PLA2 may compensate for the adiposity-associated increases in inflammatory and oxidative burden, in men."}, {"pubmed": 19578796, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19583678, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19596311, "text": "PAF acetylhydrolase activity and distribution in women with polycystic ovaries could contribute to the low-grade chronic inflammation and increased risk of atherosclerosis in these patients"}, {"pubmed": 19644070, "text": "Lp-PLA2 mass levels decrease modestly, whereas hsCRP and Lp-PLA2 activity appear stable over time. Acutely after stroke and MI, hsCRP increases whereas Lp-PLA2 mass and activity levels decrease."}, {"pubmed": 19763134, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19763134, "text": "data suggest an ethnic difference and the possible involvement of genetic polymorphisms of PLA2G7 in the prevalence of carotid atherosclerosis in the hypertensive Japanese, especially in men"}, {"pubmed": 19804884, "text": "Lp-PLA(2) mass and activity were associated with incident CVD events in older adults in CHS. Lp-PLA(2) and CRP were independent and additive in prediction of events."}, {"pubmed": 19850020, "text": "The alterations in lipoprotein profile, CETP, PON 1 and LpPLA(2) activities described in the present study indicate that non-treated iron deficiency anaemia might represent a proatherogenic state."}, {"pubmed": 19886071, "text": "Patients with ischemic stroke and severe inflammatory reaction presented Lp-PLA2 (lipoprotein-associated phospholipase A2 ) with high levels more frequently than the healthy controls"}, {"pubmed": 19892409, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19892409, "text": "PLA2G7 may influence the clinical manifestation of schizophrenia."}, {"pubmed": 19910444, "text": "oxLDL, and more specifically its unhydrolyzed oxidized phospholipids, can up-regulate lp-PLA2 expression in monocytes through the PI3K and p38 MAPK pathway"}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19948975, "text": "Observational study of gene-disease association, gene-gene interaction, gene-environment interaction, and genetic testing. (HuGE Navigator)"}, {"pubmed": 20067121, "text": "Patients with polycystic ovary syndrome have similar total plasma PAF-AH activity as healthy women."}, {"pubmed": 20080080, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20080080, "text": "recessive effects of Lp-PLA(2) V279F on LDL-cholesterol and significant correlations between Lp-PLA(2) activity and LDL-cholesterol, 8-epi-PGF(2alpha) and fibrinogen support a pro-oxidative or pro-atherogenic role for this enzyme"}, {"pubmed": 20185515, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20185811, "text": "Levels of Lp-PLA(2) activity were significantly associated with incident CHD among men and women with type 2 diabetes, independent of traditional and inflammatory risk factors."}, {"pubmed": 20200624, "text": "of 33 studies that met inclusion criteria, 30 showed a significant association between Lp-PLA2 and cardiovascular events; available body of evidence suggests that Lp-PLA2 is a reliable marker of risk for cardiovascular events [systematic review]"}, {"pubmed": 20331434, "text": "Studies designed to evaluate the ability of precursor forms of PAF-AH to mature to fully active proteins indicated that the N-terminal end of human and mouse PAF-AH played important and opposite roles in this process."}, {"pubmed": 20367923, "text": "The elevated L-PAF-AH activity may be associated with insulin resistance in polycystic ovary syndrome patients."}, {"pubmed": 20442857, "text": "analyses demonstrate that genetic polymorphisms may contribute to inter-individual variation in Lp-PLA(2) activity and mass."}, {"pubmed": 20444451, "text": "Lp-PLA(2) activity is associated with allele-specific apo(a) levels, but this association differs across African American-Caucasian ethnicity"}, {"pubmed": 20479152, "text": "Meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20479152, "text": "Unlike Lp-PLA2 activity, PLA2G7 variants associated with modest effects on Lp-PLA2 activity were not associated with cardiovascular risk markers, coronary atheroma, or coronary heart disease."}, {"pubmed": 20507838, "text": "The oxidative modification of low density lipoproteins and the higher activity of PAF-AH are related with the low Mg status."}, {"pubmed": 20625038, "text": "patients with beta-thalassemia exhibit high plasma Lp-PLA(2) levels"}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20634581, "text": "Genetic deficiency of Lp-PLA2 activity is not associated with a reduced risk of AD in the Japanese population."}, {"pubmed": 20634581, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20926117, "text": "Meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20926117, "text": "Variants of PLA2G7 gene have been reported to be associated with coronary heart disease (CHD)"}, {"pubmed": 21107710, "text": "The V279F polymorphism in LP-PLA2 gene may contribute to coronary heart disease development."}, {"pubmed": 21155029, "text": "Taiwanese female vegetarians have lower serum Lp-PLA2 activity."}, {"pubmed": 21176638, "text": "LPS significantly upregulated Lp-PLA(2) in macrophages, and simvastatin suppressed this upregulation by inhibiting the p38MAPK pathway."}, {"pubmed": 21247435, "text": "lipoprotein-associated phospholipase A2 activity was significantly increased in Metabolic Syndrome subgroups when compared with controls, and was higher in patients with carotid plaques than those without plaques"}, {"pubmed": 21281786, "text": "The PLA2G7, HPGD, EPHX2, and CYP4F8 genes are highly expressed in prostate cancer."}, {"pubmed": 21316774, "text": "Of the inflammation markers, Lp-PLA2 levels are significantly higher in patients with good coronary collateral (CC) development than with poor CC in patients with isolated left coronary artery disease."}, {"pubmed": 21432021, "text": "Data show that the proinflammatory mediators, lipopolysaccharide and platelet-activating factor, increased levels of platelet-activating factor acetylhydrolase mRNA via distinct signaling pathways."}, {"pubmed": 21476960, "text": "Multiple regression analysis showed that apo B was significantly associated with LP-PLA2 adjusted for age, Body mass index, triglycerides and LDL-C (R2=0.32)."}, {"pubmed": 21490708, "text": "Natural deficiency in Lp-PLA activity due to carriage of PLA2G7 279F allele protects from CAD in Korean men."}, {"pubmed": 21553808, "text": "Lipoprotein-associated phospholipase A(2) interacts with phospholipid vesicles via a surface-disposed hydrophobic alpha-helix"}, {"pubmed": 21606947, "text": "Lp-PLA2 activity was significantly lower in rare non-synonymous single-nucleotide polymorphisms carriers compared with non-carriers and seven variants had enzyme activities consistent with a null allele."}, {"pubmed": 21616491, "text": "analysis of genetic and environmental regulation of inflammatory CVD biomarkers Lp-PLA2 and IgM anti-PC"}, {"pubmed": 21620406, "text": "Lipoprotein-associated phospholipase A2 may have a role in symptomatic intracranial atherosclerotic disease"}, {"pubmed": 21708876, "text": "Lp-PLA(2) is not associated with endothelial dysfunction, suggesting its role in atherosclerosis development is primarily related to other factors."}, {"pubmed": 21714927, "text": "Whites have the highest Lp-PLA mass and activity levels, followed by Hispanics and Asians, and then African-Americans; in age- and sex-adjusted analyses, these differences are significant for each non-White race when compared to Whites."}, {"pubmed": 21834908, "text": "We conclude that there is significant association between the rs16874954 mutation and CAD in the Chinese Han population."}, {"pubmed": 21880383, "text": "subjects carrying the Ala/Val genotype are less likely to have essential hypertension, while hypertensive patients carrying the Ala/Val genotype have elevated fibrinogen levels"}, {"pubmed": 21882811, "text": "both the myristoyl group and the hydrophobic patch are essential for proper trafficking of the enzyme to the membranes following oxidative stress"}, {"pubmed": 21933589, "text": "Plasma Lp-PLA(2) activity is associated with plaque rupture in patients with CAD, independently of traditional CAD risk factors, hs-CRP level and IVUS parameters."}, {"pubmed": 21942556, "text": "Data indicate that LpPLA2 seems to be a biomarker constantly correlated with heart failure, regardless of etiology."}, {"pubmed": 22024276, "text": "Circulating Lp-PLA2 levels are associated with coronary plaque regression determined by intravascular ultrasonography in patients with acute coronary syndrome."}, {"pubmed": 22028154, "text": "Serum level of Lp-PLA is associated with both eccentricity index and fibrous cap thickness in both UA and SA groups. Elevated levels of circulating Lp-PLA might to be a strong risk factor and more serious for unstable angina than stable angina."}, {"pubmed": 22139405, "text": "Serum platelet-activating factor acetylhydrolase levels were increased in patients with systemic sclerosis and associated with a lower frequency of pitting scars/digital ulcers and arthritis/ arthralgias."}, {"pubmed": 22153151, "text": "Lp-PLA2 mass may add relevant information regarding early arterial recanalization in intravenous tissue-type plasminogen activator treated stroke patients."}, {"pubmed": 22164942, "text": "Lipoprotein associated phospholipase A2 (Lp-PLA2) is an inflammatory biomarker which provides information on plaque inflammation and stability; it is expressed in macrophages and foam cells in rupture-prone atherosclerotic plaque."}, {"pubmed": 22178747, "text": "Lipoprotein-associated phospholipase A(2) activity is associated with large-artery atherosclerotic etiology and recurrent stroke in transient ischemic attack patients."}, {"pubmed": 22197603, "text": "apoE-containing HDL has a relatively high PAF-AH activity in patients with polycystic ovary syndrome."}, {"pubmed": 22202492, "text": "PLA2G7 is a cancer-selective biomarker in 50 % of prostate cancers and associates with aggressive disease."}, {"pubmed": 22246459, "text": "Lp-PLA2 mass is altered in multiple scelrosis patients compared to healthy controls"}, {"pubmed": 22300679, "text": "Lp-PLA(2) and PCSK9 levels were both correlated positively with LDL cholesterol and non-high-density lipoprotein (HDL) cholesterol and Lp-PLA(2) was inversely related to PCSK9."}, {"pubmed": 22338104, "text": "In this population-based cohort enriched with dysmetabolic phenotypes, LpPLA(2) mass and activity showed divergent associations with cardiovascular diseases."}, {"pubmed": 22340269, "text": "Common genetic variation in PLA2G7 is associated with subclinical coronary atherosclerosis."}, {"pubmed": 22359537, "text": "The lack of relation between circulating Lp-PLA(2) activity and Lp-PLA(2) activity in PBMCs was found in postmenopausal women with high ox-LDL"}, {"pubmed": 22447189, "text": "Elevated Lp-PLA(2) mRNA expression is associated with acute ischemic stroke."}, {"pubmed": 22499993, "text": "The associations among Lp-PLA2, lysophosphatidylcholine, and proinflammatory cytokines in human plaques suggest that lysoPCs play a key role in plaque inflammation and vulnerability."}, {"pubmed": 22632920, "text": "The presence of the apo E4 isoform was associated with a higher level of Lp-PLA(2) index, a marker of vascular inflammation, synergistically increasing cardiovascular risk."}, {"pubmed": 22665167, "text": "associations between Lp-PLA(2) and vascular disease"}, {"pubmed": 22755553, "text": "It was concluded that Lp-PLA2 may be a new useful biomarker to evaluate clinical or subclinical activity of the disease besides CRP and ESR"}, {"pubmed": 22784637, "text": "variability of Lp-PLA(2) across gender, ethnicity, and levels of circulating lipids and markers of systemic inflammation are more consistent and appear not to vary importantly across categories defined by CVD or its risk factors."}, {"pubmed": 22797139, "text": "The neonates of women with severe preeclampsia had significantly higher plasma PAF-AH levels."}, {"pubmed": 22859728, "text": "In the WHI-OS Lp-PLA2 mass, but not activity, was independently associated with CVD. However, model fit did not significantly improve with Lp-PLA2 mass, and assay calibration remains a clinical concern"}, {"pubmed": 22898284, "text": "Val279Phe SNPs in the 9th exon of PAF-AH may be associated with intracranial hemorrhage in preterm infants."}, {"pubmed": 23083783, "text": "Total plasma Lp-PLA(2) is a predictor of cardiac death, while HDL-Lp-PLA(2) is associated with lower risk for cardiac death in patients with stable CAD"}, {"pubmed": 23089713, "text": "aortic valve stenosis (AVS) is characterized by increased plasma Lp-PLA2 levels associated with the severity of AVS"}, {"pubmed": 23089916, "text": "the interaction between recombinant human Lp-PLA(2) and human HDL"}, {"pubmed": 23103135, "text": "Lp-PLA2 levels are significantly associated with coronary heart disease."}, {"pubmed": 23118945, "text": "High Lp-PLA2 activity implies a worse prognosis at long term follow up in high-risk Caucasian patients referred for coronary angiography."}, {"pubmed": 23140470, "text": "Our results demonstrated dynamic alterations in Lp-PLA2 levels during the early stages of ACS and, therefore, indirectly support the hypothesis of an active role for Lp-PLA2 in the pathogenesis of ACS."}, {"pubmed": 23361301, "text": "PLA2G7 expression is elevated in colon tumors compared with normal tissues."}, {"pubmed": 23413990, "text": "Lp-PLA2 activity changes in obesity and it shows important associations with markers of cardiovascular risk."}, {"pubmed": 23439604, "text": "Darapladib produced sustained inhibition of Lp-PLA2 activity in Japanese dyslipidemic patients with/without the V279F SNP of Lp-PLA2."}, {"pubmed": 23546765, "text": "Prediabetes patients have significantly decreased high-density lipoprotein-LP-PLA2 activity compared with subjects with glucose levels <100 mg/dL."}, {"pubmed": 23555769, "text": "PLA2G7 gene promoter methylation increases the risk of coronary heart disease in females"}, {"pubmed": 23623642, "text": "SAA up-regulates Lp-PLA2 production significantly via a FPRL1/MAPKs./PPAR-gamma signaling pathway."}, {"pubmed": 23746626, "text": "There was no significant association between baseline Lp-PLA2 quartiles and risk of venous thromboembolism."}, {"pubmed": 23747086, "text": "The reduced levels of Lp-PLA2 and suPAR in human carotid plaques of subjects on long-term treatment with beta-blockers suggest their possible protective role in plaque inflammation."}, {"pubmed": 24008317, "text": "Taken together, our findings uncover an unanticipated tumor suppressive role for PLA2R1 that is mediated by targeting downstream JAK2 effector signaling."}, {"pubmed": 24089018, "text": "Significant associations between serial changes in Lp-PLA2 activity and changes in fibrous cap thickness and plaque volume were observed in patients with acute coronary syndromes."}, {"pubmed": 24092915, "text": "relative increase of apoB/Lp-PLA2 in hypercholesterolemic patients"}, {"pubmed": 24161325, "text": "Lp-PLA2 is highly expressed in CAVD, and it plays a role in the mineralization of valve interstitial cells."}, {"pubmed": 24358251, "text": "In smokers a further effect of raised oxidative stress is the up-regulation of Lp-PLA2 expression in PBMC with subsequent increase of plasma Lp-PLA2 and lysophosphatidylcholine."}, {"pubmed": 24393260, "text": "Blood serum levels of LP-PLA2 in a healthy Chinese Han population."}, {"pubmed": 24397392, "text": "Data suggest that, two years after delivery, plasma levels of PLA2G7 and advanced glycation end products are up-regulated in women who had gestational diabetes; these levels may be biomarkers of increased risk for metabolic/cardiovascular diseases."}, {"pubmed": 24416164, "text": "LpPLA2-mass levels were associated with risk of atherosclerotic stroke among non-Hispanic White participants, but not in other race-ethnic groups in the cohort."}, {"pubmed": 24463064, "text": "The study indicated that the A379V variant in PLA2G7 gene might contribute to ischemic stroke susceptibility in northern Chinese Han population."}, {"pubmed": 24492522, "text": "Lp-PLA2 may play an important role in the pathogenesis of atherosclerosis"}, {"pubmed": 24513482, "text": "Lp-PLA2 mass and activity could provide different information in the hyperacute stage of stroke"}, {"pubmed": 24555913, "text": "Administration of omega-3 PUFA can decrease Lp-PLA2 in patients with stable angina undergoing percutaneous coronary intervention."}, {"pubmed": 24580749, "text": "Increased Lp-PLA2 levels are associated with an increased risk of re-stenosis."}, {"pubmed": 24682749, "text": "A reduction in oxidative stress was seen in Korean subjects carrying the 379V allele of the Lp-PLA 2 gene."}, {"pubmed": 24732951, "text": "in high-risk coronary artery disease patients of European ancestry, the PLA2G7 rs1805017 GG genotype is associated with increased Lp-PLA2 plasma activity and acute myocardial infarction"}, {"pubmed": 24742198, "text": "after clopidogrel and cilostazol combination therapy, galectin-3 level, lipoprotein-associated phospholipase A2 gene expression, and RhoA/ROCK-related protein expression in peripheral blood mononuclear cells were significantly suppressed"}, {"pubmed": 24818163, "text": "Data suggest plasma Lp-PLA2 is upregulated in elderly subjects, in subjects with type 2 diabetes, and is further upregulated in subjects treated for severe aortic stenosis with TAVI (transcatheter aortic valve implantation)/BA (balloon angioplasty)."}, {"pubmed": 24904022, "text": "The substitution of whole grains and legumes for refined rice resulted in a reduction in Lp-PLA2 activities in plasma and PBMCs partly through improved glycemic control, increased consumption of protein relative to carbohydrate, and reduced lipid peroxides."}, {"pubmed": 24930071, "text": "Blood LP-PLA2 level was inversely related to impaired glucose metabolism in patients with stable vascular disease."}, {"pubmed": 25056687, "text": "Lp-PLA2 and TNF-alpha are significantly increased in thalassemia children and show strong correlations with carotid intima-media thickness."}, {"pubmed": 25078067, "text": "the natural absence of the plasma Lp-PLA2 activity due to carriage of the Lp-PLA2 279FF genotype may reduce the generation of lysoPC (16:0) and oleamide and thereby enhance the activity of plasma tryptophan in normal physiological processes"}, {"pubmed": 25105582, "text": "LpPLA2 mass was not associated with coronary or carotid subclinical atherosclerosis in retired NFL players."}, {"pubmed": 25186013, "text": "Inhibition of PAF acetylhydrolase resulted in inhibition of breast cancer cell adherence."}, {"pubmed": 25291938, "text": "Small, dense LDL and Lp-PLA2 concentrations are increased independently in the end stage renal failure patients who are receiving dialysis treatment."}, {"pubmed": 25458708, "text": "It is assumed that Lp-PLA2 is involved in vascular calcification and that dp-ucMGP is a more appropriate biomarker of residual risk than Lp-PLA2 itself."}, {"pubmed": 25463126, "text": "lipoprotein-associated phospholipase A2 has a role in silent brain infarcts in women"}, {"pubmed": 25501698, "text": "These findings suggest that plasma PAF may be a potential biomarker for predicting poor bone health in postmenopausal women."}, {"pubmed": 25581763, "text": "miR-183 and miR-205 failed to detect early and aggressive PCa despite their highly dysregulated expression in cancer tissue"}, {"pubmed": 25587968, "text": "In our study, we found that PLA2G7 variants that reduce lipoprotein-associated phospholipase A2 activity to a degree similar to activity associated with darapladib have no effect on the risk of coronary heart disease."}, {"pubmed": 25647459, "text": "The presence of subclinical coronary atherosclerosis is associated independently with Lp-PLA2, and it has potential utility as a novel indicator of cardiovascular disease risk in the young adult population."}, {"pubmed": 25690150, "text": "These findings indicated that R92H variant in PLA2G7 gene might contribute to CHD susceptibility in a southern Chinese population."}, {"pubmed": 25874928, "text": "Data suggest that sub-acute autoimmune inflammatory disease progresses independently of lipoprotein-associated phospholipase A2 (Lp-PLA2) activity."}, {"pubmed": 25893499, "text": "Cytosolic phospholipase A2 modulates TLR2 signaling in synoviocytes."}, {"pubmed": 25934512, "text": "Lp-PLA2 concentrations were positively associated with all LDL subfractions and small HDL subfraction, suggesting an interaction between Lp-PLA2 and lipoprotein subfraction phenotypes in the status of coronary artery disease."}, {"pubmed": 26004387, "text": "In multi-ethnic cohort, Lp-PLA2 was positively associated with CVD risk, regardless of the presence of coronary artery calcium or a thickened carotid-intimal media."}, {"pubmed": 26117401, "text": "Lipoprotein associated phospholipase A2 activity and apolipoprotein C3 loss-of-function variants are involved in cardiovascular disease"}, {"pubmed": 26311748, "text": "Higher levels of Lp-PLA2-A in the acute period after TIA or minor stroke are associated with increased short-term risk of recurrent vascular events."}, {"pubmed": 26460076, "text": "Expression of LpPLA2 may be associated with obesity. Therefore, LpPLA2 mRNA expression levels may develop as an important risk predictor for vascular complications in Metabolic syndrome."}, {"pubmed": 26499399, "text": "This presentation aims at clarifying the involvement of Lp-PLA2 in the pathophysiology of atherosclerosis, and at assessing its interest both as a biomarker for the onset of CV events and as a therapeutic target--{REVIEW}"}, {"pubmed": 26504820, "text": "Studied whether the level of Lp-PLA2 is associated with subclinical atherosclerosis in patients with rheumatoid arthritis."}, {"pubmed": 26595893, "text": "279Val-->Phe Polymorphism of Lp-PLA2 may lead to decrease the enzymatic activity via changes of folding kinetics and recognition to its substrate."}, {"pubmed": 26642708, "text": "circulating CETP and Lp-PLA2 might partly play a role in the atherogenic disturbances in patients with iron deficiency anemia through increased susceptibility to lipid peroxidation"}, {"pubmed": 26775119, "text": "Lp-PLA2 activity in Japanese men aged 50-79 years was associated significantly and positively with IMT and plaque in the carotid artery but Mendelian randomization did not support that Lp-PLA2 is a causative factor for subclinical atherosclerosis."}, {"pubmed": 26791069, "text": "A V279F loss-of-function variant in the PLA2G7 gene resulting in 50% lower activity for each copy of the variant, is common in East Asians and associated with risk of Vascular diseases."}, {"pubmed": 26801405, "text": "Increased plasma Lp-PLA2 activity portends increased risk of resistant hypertension."}, {"pubmed": 26828804, "text": "no relationship with either proinflammatory cytokines or neopterin identified in Alzheimer disease"}, {"pubmed": 26848158, "text": "Higher Lp-PLA2 mass and activity were associated with development of both incident clinical peripheral arterial disease and low ankle brachial index."}, {"pubmed": 27097870, "text": "results do not support added value of Lp-PLA2 for predicting cardiovascular events or mortality among CHD patients beyond traditional risk factor"}, {"pubmed": 27206945, "text": "LpPLA2 is found in both LDL and HDL and is distributed differently in men with T1D without any relationship to CAC score progression"}, {"pubmed": 27301456, "text": "Lifelong lower Lp-PLA2 activity was not associated with major risks of vascular or non-vascular diseases in Chinese adults."}, {"pubmed": 27392709, "text": "Taken together, these results revealed that Lp-PLA2 silencing protected against ox-LDL-induced oxidative stress and cell apoptosis via Akt/mTOR signaling pathway in human THP1 macrophages."}, {"pubmed": 27450918, "text": "PLA2G7 gene expression was co-regulated by 17-beta-estradiol and promoter methylation."}, {"pubmed": 27461004, "text": "Data show that all the six inflammation-related CpG-SNPs genotypes including IL1B rs16944, IL1R2 rs2071008, PLA2G7 rs9395208, FAM5C rs12732361, CD40 rs1800686, and CD36 rs2065666 were associated with coronary heart disease (CHD), suggesting an important role of inflammation in the risk of CHD."}, {"pubmed": 27487154, "text": "phospholipase A2 Group 7 (PLA2G7), to be important in regulating tumor cell migration and a novel tumor-promoting factor in nasopharyngeal carcinoma."}, {"pubmed": 27614353, "text": "Lipoprotein-associated phospholipase A2 as a new marker to determine cardiovascular risk in hypercholesterolemic dyslipidaemic children"}, {"pubmed": 27641736, "text": "A considerable portion of Chinese ischemic stroke patients are insensitive to aspirin treatment, which may be correlated with the MDR1 C3435T, TBXA2R (rs1131882), and PLA2G7 (rs1051931-rs7756935) polymorphisms."}, {"pubmed": 27710915, "text": "High Lp-PLA2 expression is associated with type 1 diabetes."}, {"pubmed": 27776715, "text": "Elevated mass and activity of Lp-PLA2 related to inflammation and atherosclerosis may take part in the development of kidney injury and atherosclerosis in patients with chronic kidney disease."}, {"pubmed": 27905470, "text": "A PLA2G7 gene polymorphism determines the plasma levels of lipoprotein-associated phospholipase A2 activity and mass and manifests as a risk factor for atherosclerosis."}, {"pubmed": 27928450, "text": "The collected data showed a correlation between the occurrence of superimposed thrombosis in respiratory infection patients, and the intensity of the inflammatory process, reflected by the increased MPO activity, and the dynamics of LpPLA2 and VEGF."}, {"pubmed": 27941334, "text": "Lp-PLA2 levels in human plasma were positively associated with the severity of coronary heart disease."}, {"pubmed": 27956130, "text": "Greater Lp-PLA2 activity or mass was independently associated with cardiovascular events in patients with coronary heart disease, particularly in patients with stable coronary heart disease who were not receiving therapies for inhibiting Lp-PLA2.[review]"}, {"pubmed": 27992874, "text": "Uremic environment but not inflammation per se increases plasma Lp-PLA2 activity and upregulates monocytic Lp-PLA2 mRNA expression. The highest Lp-PLA2 levels were found in the classical and not in the inflammatory subsets. Atherosclerosis also contributes to a subset-specific increase in Lp-PLA2 mRNA expression."}, {"pubmed": 28005267, "text": "PLA2G7 expression is significantly upregulated in human masticatory mucosa during wound healing"}, {"pubmed": 28110894, "text": "High levels of high-sensitive C-reactive protein and lipoprotein-associated phospholipase-A2 did not relate to endothelial dysfunction in ST-elevation myocardial infarction patients treated with percutaneous coronary intervention."}, {"pubmed": 28142077, "text": "In persistent prehypertension, increased ox-LDL hydrolysis by Lp-PLA2 enhances arterial stiffness without an age-related increase in blood pressure."}, {"pubmed": 28215109, "text": "In a multi-ethnic cohort without baseline cardiovascular disease, higher Lp-PLA2 mass and activity were not significantly associated with an increased risk for incident peripheral arterial disease."}, {"pubmed": 28222638, "text": "Plasma Lp-PLA2 concentration was independently associated with coronary heart disease in Chinese patients."}, {"pubmed": 28332853, "text": "The distribution of V279F-AA+AC genotype and R92H-AA+AG genotype in the AP group was higher than that in the control group, whereas the Severity of Acute Pancreatitis (SAP) group and SAP with multiple organ dysfunction syndrome group distributions were higher than those in the MAP group and SAP without MODS group.G-C-A, G-A-G, and G-C-G haploids formed by A379V, V279F, and R92H may be associated with AP susceptibility"}, {"pubmed": 28334001, "text": "The simultaneous presence of the PLA2G7 279VV genotype and persistence of overweight synergistically increases the risk for hypertension."}, {"pubmed": 28475940, "text": "Suggest that the plasma biomarkers Lp-PLA2 activity and mass are markers of abdominal aortic aneurysm risk after adjusting for relevant confounders."}, {"pubmed": 28502488, "text": "Lipoprotein-associated phospholipase A2 and its relationship with markers of subclinical cardiovascular disease"}, {"pubmed": 28514697, "text": "Greater Lp-PLA2 activity or mass was associated with an increased risk of CHD and IS"}, {"pubmed": 28608449, "text": "Resveratrol downregulates Lp-PLA2 expression by inhibiting oxidative stress via SIRT1 pathway in the THP-1-derived macrophages."}, {"pubmed": 28704853, "text": "Conclusion RBP4 may be used as a predictive factor of diabetic nephropathy patients complicated with silent cerebral infarction (SCI) and is positively correlated with cognitive dysfunction. RBP4/Lp-PLA2/Netrin-1 pathway activation may be one of the occurrence mechanisms in diabetic nephropathy complicated with SCI."}, {"pubmed": 28784006, "text": "in preeclampsia, higher vascular inflammation which was shown by Lp-PLA2 mass, Lp-PLA2 index, and PTX3 levels were significantly associated with rs9381475, rs1051931 carriers. Further, Lp-PLA2 activity and PTX3, Lp-PLA mass has independently associated with early preeclampsia."}, {"pubmed": 28934604, "text": "Elevated Lp-PLA2 mass was associated with all cause-death independently of other risk factors within one year after acute ischemic stroke."}, {"pubmed": 28951620, "text": "Study indicated that increased levels of Lp-PLA2 mass, Lp-PLA2 activity, and high sensitivity C reactive protein are associated with mild cognitive impairment (MCI) in type 2 diabetes mellitus (T2DM) Chinese patients. These biomarkers are related to inflammation, thereby suggesting potential inflammatory reaction mechanisms underlying T2DM-associated MCI."}, {"pubmed": 28960681, "text": "Lp-PLA2 G994T gene polymorphism may be an independent risk factor of ischemic stroke in Chinese population."}, {"pubmed": 29027597, "text": "The decrease of Lp-PLA2 activity in adolescents with type 2 diabetes suggests that elevated blood glucose concentrations do not have a dominant elevating effect, perhaps even a decreasing influence on Lp- PLA2 activity."}, {"pubmed": 29050675, "text": "PLA2G7 and PON1 are overexpressed in prostatic neoplasm patients and can be detected early in blood."}, {"pubmed": 29101839, "text": "CD163 positive macrophages have roles in lipoprotein-associated phospholipase A2 activity in atherosclerotic plaque"}, {"pubmed": 29121808, "text": "evidence that Lp-PLA2 could predict all-cause mortality and rehospitalization risk among patients with ACS undergoing PCI."}, {"pubmed": 29138849, "text": "Persistently elevated serum concentrations of Lp-PLA2 were associated with an unfavorable outcome in patients with sepsis."}, {"pubmed": 29169030, "text": "While higher Lp-PLA2 activity was associated with an increased risk for incident peripheral arterial disease, it is likely a risk marker largely represented by traditional risk factors."}, {"pubmed": 29424477, "text": "Lp-PLA2 mass is positively correlated with subclinical atherosclerosis determined by asymptomatic cerebral artery stenosis (ACAS), ICAS and ECAS in North Chinese, particularly in male and older participants, suggesting that serum Lp-PLA2 mass might be potential biomarker for the detection of ACAS in the adults."}, {"pubmed": 29427237, "text": "adipose tissue and adipocytes are active sources of Lp-PLA2, with differential regulation by fat depot and metabolic state"}, {"pubmed": 29427679, "text": "Met117 oxidation caused enhanced flexibility and decreased compactness in oxidized state. PAF binding interaction with oxidized protein was mediated only through hydrophobic interactions."}, {"pubmed": 29525223, "text": "Lp-PLA2 activity was higher in definite FH than in non-definite FH patients independently of LDL-C levels and statin treatment."}, {"pubmed": 29623345, "text": "Lp-PLA2 increases are associated with increased risk of death and the development of incident diabetic retinopathy, as well as transitions to more severe grades of diabetic retinopathy"}, {"pubmed": 29636060, "text": "the relationship between two variants of apoC1 and the risk of polycystic ovary syndrome, evaluated the genotypic effects on clinical, hormonal and metabolic indexes and plasma platelet-activating factor acetylhydrolase (PAF-AH) activity, was investigated."}, {"pubmed": 29728838, "text": "Polymorphisms in rs1805017 and rs1805018, additional interaction between rs1805017 and smoking, and haplotype containing the rs1805017-H and rs1805018-T alleles were associated with increased CHD risk."}, {"pubmed": 29737567, "text": "Impact of a non-synonymous Q281R polymorphism on structure of human Lipoprotein-Associated Phospholipase A2 (Lp-PLA2 )."}, {"pubmed": 30094934, "text": "A significant association was found between high hs-CRP and Lp-PLA2 levels and carotid stenosis (adjusted odds ratio [OR]: 2.39; 95% confidence interval [CI]: 1.13-5.09), but this combination was not associated with carotid plaques (OR: 2.62, 95% CI: 0.93-7.38). The results suggested that the combination of hs-CRP and Lp-PLA2 were better predictors than either protein alone with regard to carotid atherosclerosis."}, {"pubmed": 30168082, "text": "Lp-PLA2 activity is elevated among dialyzed patients and is an independent risk factor for acute cardiovascular events."}, {"pubmed": 30289950, "text": "Results provide strong evidence for the association of rs10846744, which resides within an enhancer region, with Lp-PLA2 activity and evidence from a number of large genetic studies for association with cardiovascular disease events."}, {"pubmed": 30850840, "text": "Is Admission Lipoprotein-Associated Phospholipase A2 a Novel Predictor of Vasospasm and Outcome in Patients With Aneurysmal Subarachnoid Hemorrhage?"}, {"pubmed": 30904742, "text": "High Lp-PLA2 expression is associated with diabetic kidney disease."}, {"pubmed": 31103624, "text": "serum Lp-PLA2 as a potential prognostic biomarker of ICH"}, {"pubmed": 31115024, "text": "The association between the D166E polymorphism of the lipoprotein associated phospholipase A2 and risk of myocardial infarction."}, {"pubmed": 31236414, "text": "Elevated baseline Lp-PLA2 levels, detected either by activity or mass, are associated with increased stroke risk."}, {"pubmed": 31489677, "text": "results suggested that total energy intake and adiponectin levels are potential determinants of Lp-PLA2 activity"}, {"pubmed": 31630457, "text": "Comparison of serum Lp-PLA2 levels in ischemic stroke patients with H-type hypertension or non-H-type hypertension."}, {"pubmed": 31713292, "text": "Evaluation of lipoprotein-associated phospholipase A2, serum amyloid A, and fibrinogen as diagnostic biomarkers for patients with acute cerebral infarction."}, {"pubmed": 31875617, "text": "Lipoprotein-associated phospholipase A2 (Lp-PLA2) and high-sensitivity C-reactive protein (hs-CRP) levels were found to be associated with risk of myocardial infaction, stroke, and all-cause mortality in a Chinese population."}, {"pubmed": 32109154, "text": "Association of Serum Lipoprotein-Associated Phospholipase A2 and A379V Gene Polymorphisms with Carotid Plaques."}, {"pubmed": 32145524, "text": "Association of the G994T and R92H genotypes of platelet-activating factor acetylhydrolase with risk of preeclampsia in Chinese women."}, {"pubmed": 32152936, "text": "Methylation of Phospholipase A2 Group VII Gene Is Associated with Brain Arteriovenous Malformations in Han Chinese Populations."}, {"pubmed": 32460702, "text": "Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow."}, {"pubmed": 32546193, "text": "The relationship of lipoprotein-associated phospholipase A2 activity with the seriousness of coronary artery disease."}, {"pubmed": 32636298, "text": "Lipoprotein-associated phospholipase A2 activity, genetics and calcific aortic valve stenosis in humans."}, {"pubmed": 32648046, "text": "Serum level of lipoprotein-associated phospholipase A2 is a potential biomarker of vertebrobasilar dolichoectasia and its progression to cerebral infarction."}, {"pubmed": 32679127, "text": "Association between lipoprotein-associated phospholipase A2 and lower extremity arterial disease in type 2 diabetes mellitus."}, {"pubmed": 32710501, "text": "The Relationship Between the Level of Serum ESM-1 and Lp-PLA2 in Patients With Acute ST-Segment Elevation Myocardial Infarction."}, {"pubmed": 33029257, "text": "Relationship between Plasma Lipoprotein-Associated Phospholipase A2 Concentrations and Apolipoprotein in Stable Coronary Artery Disease Patients."}, {"pubmed": 33073951, "text": "Elevated Serum Levels of Lp-PLA2 and IL-18 are Associated with Progression of Diabetic Foot Ulcers."}, {"pubmed": 33089697, "text": "Carotid Plaque Inflammation Assessed by (18)F-FDG PET/CT and Lp-PLA2 Is Higher in Symptomatic Patients."}, {"pubmed": 33107310, "text": "Functional Analysis of RELN S2486G Mutation and its Contribution to Pathogenesis of Ankylosing Spondylitis."}, {"pubmed": 33188662, "text": "Association of Carotid Plaque and Serum Lipoprotein-Associated Phospholipase A2 (LP-PLA2) with Postoperative Delirium in Geriatric Patients Undergoing Hip Replacement: A Prospective Cohort Study."}, {"pubmed": 33299319, "text": "Expression of Hypoxia-Inducible Factor-1alpha (HIF1A) and Lp-PLA2 in Low, Intermediate, and High Cardiovascular Disease Risk Population."}, {"pubmed": 33458873, "text": "Lp-PLA2 evaluates the severity of carotid artery stenosis and predicts the occurrence of cerebrovascular events in high stroke-risk populations."}, {"pubmed": 33583415, "text": "Lipoprotein-associated phospholipase A2 levels, endothelial dysfunction and arterial stiffness in patients with stable coronary artery disease."}, {"pubmed": 33676381, "text": "Negative association between lipoprotein associated phospholipase A2 activity and baroreflex sensitivity in subjects with high normal blood pressure and a positive family history of hypertension."}, {"pubmed": 33760156, "text": "Hydrogen sulfide improves oxLDLinduced expression levels of LpPLA2 in THP1 monocytes via the p38MAPK pathway."}, {"pubmed": 33762651, "text": "Abnormal upregulation of cardiovascular disease biomarker PLA2G7 induced by proinflammatory macrophages in COVID-19 patients."}, {"pubmed": 33978383, "text": "Application Value of Lipoprotein-Associated Phospholipase A2 Expression Level in Evaluating the Risk of Major Bleeding in Gestational Diabetes."}, {"pubmed": 34093570, "text": "Identification of Inflammation-Related Biomarker Lp-PLA2 for Patients With COPD by Comprehensive Analysis."}, {"pubmed": 34220834, "text": "Lipoprotein-Associated Phospholipase A2: A Novel Contributor in Sjogren's Syndrome-Related Lymphoma?"}, {"pubmed": 34315293, "text": "Relationship between Lp-PLA2 and in-stent restenosis after coronary stenting: a 3-year follow-up study."}, {"pubmed": 34388201, "text": "Clinical significance of plasma PAF acetylhydrolase activity measurements as a biomarker of anaphylaxis: Cross-sectional study."}, {"pubmed": 34404374, "text": "Identification of PLA2G7 as a novel biomarker of diffuse large B cell lymphoma."}, {"pubmed": 34427055, "text": "Association of circulating PLA2G7 levels with cancer cachexia and assessment of darapladib as a therapy."}, {"pubmed": 34740601, "text": "Causal effect of Lipoprotein-associated phospholipase A2 activity on coronary artery disease and myocardial Infarction: A Two-Sample Mendelian Randomization study."}, {"pubmed": 35143297, "text": "Caloric restriction in humans reveals immunometabolic regulators of health span."}, {"pubmed": 35396721, "text": "Platelet-activating factor acetylhydrolase is a biomarker of severe anaphylaxis in children."}, {"pubmed": 35818585, "text": "Association Lp-PLA2 Gene Polymorphisms with Coronary Heart Disease."}, {"pubmed": 36517761, "text": "Correlation of lipoprotein-associated phospholipase A2 and cerebral microbleeds in patients with acute ischaemic stroke."}, {"pubmed": 36614323, "text": "PLA2G7/PAF-AH as Potential Negative Regulator of the Wnt Signaling Pathway Mediates Protective Effects in BRCA1 Mutant Breast Cancer."}, {"pubmed": 36857476, "text": "Lipoprotein-Associated Phospholipase A2 Correlates with Reduced Left Ventricle Ejection Fraction in Hemodialysis Patients."}, {"pubmed": 36946054, "text": "[Serum lipoprotein-associated phospholipase A2 level is positively correlated with the recurrence risk of acute ischemic cerebral infarction in hypertensive patients]."}, {"pubmed": 36975077, "text": "Sudden Sensorineural Hearing Loss Is Related to Endothelial Progenitor Cells and Lipoprotein-Associated Phospholipase A2."}, {"pubmed": 37270927, "text": "Bioinformatics analysis of PLA2G7 as an immune-related biomarker in COPD by promoting expansion and suppressive functions of MDSCs."}, {"pubmed": 37566692, "text": "The diagnostic value of lipoprotein-associated phospholipase A2 in early diabetic nephropathy."}, {"pubmed": 37747445, "text": "Gender-related and PUFA-related differences in lipoprotein-associated phospholipase A2 levels in patients with type 2 diabetes and atherosclerotic cardiovascular disease."}, {"pubmed": 37761388, "text": "Lipoprotein-Associated Phospholipase A2 has Comparable Ability as Anthropometric Indices to Discriminate Cardiovascular Disease Risk: A Cross-Sectional Study."}, {"pubmed": 37933031, "text": "The association between circulating Hcy and Lp-PLA2 levels and poststroke depression: A meta-analysis."}, {"pubmed": 37975398, "text": "The value of serum lipoprotein-associated phospholipase A2, ischemia-modified albumin, and cystatin C in predicting coronary heart disease risk: a single center retrospective cohort study."}, {"pubmed": 38216940, "text": "Lipoprotein-associated phospholipase A2 predicts cardiovascular death in patients on maintenance hemodialysis: a 7-year prospective cohort study."}, {"pubmed": 38287833, "text": "Bioinformatics Analysis Identifies PLA2G7 as a Key Antigen-Presenting Prognostic Related Gene Promoting Hepatocellular Carcinoma through the STAT1/PD-L1 Axis."}, {"pubmed": 38677367, "text": "Association of 25-hydroxyvitamin D, lipoprotein-associated phospholipase A2 and asymptomatic coronary artery disease in patients with type 2 diabetes mellitus."}, {"pubmed": 38924255, "text": "The relationships between biological novel biomarkers Lp-PLA2 and CTRP-3 and CVD in patients with type 2 diabetes mellitus."}], "genomic_pos": {"chr": "6", "end": 46735693, "ensemblgene": "ENSG00000146070", "start": 46704201, "strand": -1}, "genomic_pos_hg19": {"chr": "6", "end": 46703430, "start": 46671938, "strand": -1}, "go": {"BP": [{"evidence": "TAS", "gocategory": "BP", "id": "GO:0016486", "qualifier": "involved_in", "term": "peptide hormone processing"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0034374", "pubmed": 8624782, "qualifier": "involved_in", "term": "low-density lipoprotein particle remodeling"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0034440", "pubmed": 8624782, "qualifier": "involved_in", "term": "lipid oxidation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0034441", "pubmed": 8624782, "qualifier": "involved_in", "term": "plasma lipoprotein particle oxidation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0034638", "pubmed": 2040620, "qualifier": "involved_in", "term": "phosphatidylcholine catabolic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0046469", "pubmed": [8624782, 10066756, 10504265, 11590221], "qualifier": "involved_in", "term": "platelet activating factor metabolic process"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0050729", "pubmed": 8624782, "qualifier": "involved_in", "term": "positive regulation of inflammatory response"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0062234", "pubmed": 16371369, "qualifier": "involved_in", "term": "platelet activating factor catabolic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0090026", "pubmed": 8624782, "qualifier": "involved_in", "term": "positive regulation of monocyte chemotaxis"}], "CC": [{"evidence": "TAS", "gocategory": "CC", "id": "GO:0005576", "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0034362", "pubmed": [8624782, 10066756, 12821559], "qualifier": "part_of", "term": "low-density lipoprotein particle"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0034364", "pubmed": 11590221, "qualifier": "part_of", "term": "high-density lipoprotein particle"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0003847", "qualifier": "enables", "term": "1-alkyl-2-acetylglycerophosphocholine esterase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0003847", "pubmed": [8624782, 10066756, 10504265, 11590221, 16371369], "qualifier": "enables", "term": "1-alkyl-2-acetylglycerophosphocholine esterase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0005543", "pubmed": 8624782, "qualifier": "enables", "term": "phospholipid binding"}, {"category": "MF", "evidence": "TAS", "id": "GO:0016788", "qualifier": "enables", "term": "hydrolase activity, acting on ester bonds"}, {"category": "MF", "evidence": "IDA", "id": "GO:0047499", "pubmed": [2040620, 8624782], "qualifier": "enables", "term": "calcium-independent phospholipase A2 activity"}]}, "homologene": {"genes": [[7955, 406470], [8364, 550021], [9031, 395816], [9544, 704566], [9598, 462744], [9606, 7941], [9615, 403848], [9913, 282311], [10090, 27226], [10116, 301265]], "id": 3725}, "interpro": [{"desc": "Platelet-activating factor acetylhydrolase-like, eukaryote", "id": "IPR016715", "short_desc": "PAF_acetylhydro_eukaryote"}, {"desc": "Alpha/Beta hydrolase fold", "id": "IPR029058", "short_desc": "AB_hydrolase"}], "ipi": ["IPI00011588", "IPI01010133", "IPI01014627"], "map_location": "6p12.3", "name": "phospholipase A2 group VII", "other_names": ["1-alkyl-2-acetylglycerophosphocholine esterase", "2-acetyl-1-alkylglycerophosphocholine esterase", "LDL-PLA(2)", "LDL-associated phospholipase A2", "PAF 2-acylhydrolase", "PAF acetylhydrolase", "gVIIA-PLA2", "group-VIIA phospholipase A2", "lipoprotein-associated phospholipase A2", "phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)", "platelet-activating factor acetylhydrolase"], "pantherdb": {"HGNC": "9040", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1351327", "ortholog_type": "LDO", "panther_family": "PTHR10272", "taxid": 10090, "uniprot_kb": "Q60963"}, {"RGD": "1310734", "ortholog_type": "LDO", "panther_family": "PTHR10272", "taxid": 10116, "uniprot_kb": "Q5M7T7"}, {"Ensembl": "ENSGALG00000016713", "ortholog_type": "LDO", "panther_family": "PTHR10272", "taxid": 9031, "uniprot_kb": "F1NF09"}, {"Gene": "PLA2G7", "ortholog_type": "LDO", "panther_family": "PTHR10272", "taxid": 9031, "uniprot_kb": "Q90678"}, {"ZFIN": "ZDB-GENE-040426-2248", "ortholog_type": "LDO", "panther_family": "PTHR10272", "taxid": 7955, "uniprot_kb": "Q5RHM0"}, {"WormBase": "WBGene00003906", "ortholog_type": "O", "panther_family": "PTHR10272", "taxid": 6239, "uniprot_kb": "G5EGT1"}, {"WormBase": "WBGene00003907", "ortholog_type": "LDO", "panther_family": "PTHR10272", "taxid": 6239, "uniprot_kb": "Q22943"}, {"PomBase": "SPBC106.11c", "ortholog_type": "LDO", "panther_family": "PTHR10272", "taxid": 4896, "uniprot_kb": "Q9URV1"}], "uniprot_kb": "Q13093"}, "pathway": {"kegg": {"id": "hsa00565", "name": "Ether lipid metabolism - Homo sapiens (human)"}, "pid": {"id": "lis1pathway", "name": "Lissencephaly gene (LIS1) in neuronal migration and development"}, "reactome": [{"id": "R-HSA-2980736", "name": "Peptide hormone metabolism"}, {"id": "R-HSA-392499", "name": "Metabolism of proteins"}, {"id": "R-HSA-422085", "name": "Synthesis, secretion, and deacylation of Ghrelin"}], "wikipathways": [{"id": "WP2865", "name": "IL1 and megakaryocytes in obesity"}, {"id": "WP4754", "name": "IL-18 signaling pathway"}]}, "pdb": ["3D59", "3D5E", "3F96", "3F97", "3F98", "3F9C", "5I8P", "5I9I", "5JAD", "5JAH", "5JAL", "5JAN", "5JAO", "5JAP", "5JAR", "5JAS", "5JAT", "5JAU", "5LP1", "5LYY", "5LZ2", "5LZ4", "5LZ5", "5LZ7", "5LZ8", "5LZ9", "5YE7", "5YE8", "5YE9", "5YEA", "6M06", "6M07", "6M08"], "pfam": "PF03403", "pharmgkb": "PA33368", "pharos": {"target_id": 19094, "tdl": "Tchem"}, "pir": "S60247", "reagent": {"CM-LibrX-no-seq": [{"id": "GNF326471", "relationship": "is"}, {"id": "GNF326472", "relationship": "is"}, {"id": "GNF326473", "relationship": "is"}], "GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF258223", "relationship": "is"}, {"id": "GNF258224", "relationship": "is"}, {"id": "GNF258225", "relationship": "is"}, {"id": "GNF258226", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF048380", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF087467", "relationship": "is"}, {"id": "GNF087468", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF050721", "relationship": "is"}, {"id": "GNF055484", "relationship": "is"}, {"id": "GNF060128", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF065291", "relationship": "is"}, {"id": "GNF065292", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF011308", "relationship": "is"}, "GNF_mm+hs_RetroCDNA": {"id": "GNF238759", "relationship": "is"}, "MasterSecretomicsList": [{"id": "GNF330918", "relationship": "is"}, {"id": "GNF332443", "relationship": "is"}, {"id": "GNF333237", "relationship": "is"}], "NIBRI_hs-Secretome_pDEST": {"id": "GNF338613", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF097352", "relationship": "is"}, {"id": "GNF137007", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000006.12", "NC_060930.1", "NG_016204.1"], "protein": ["NP_001161829.1", "NP_005075.3", "XP_005249465.1", "XP_047275315.1", "XP_047275316.1", "XP_054212394.1", "XP_054212395.1"], "rna": ["NM_001168357.2", "NM_005084.4", "XM_005249408.5", "XM_047419359.1", "XM_047419360.1", "XM_054356419.1", "XM_054356420.1"], "translation": [{"protein": "NP_001161829.1", "rna": "NM_001168357.2"}, {"protein": "XP_047275315.1", "rna": "XM_047419359.1"}, {"protein": "XP_047275316.1", "rna": "XM_047419360.1"}, {"protein": "XP_005249465.1", "rna": "XM_005249408.5"}, {"protein": "NP_005075.3", "rna": "NM_005084.4"}, {"protein": "XP_054212395.1", "rna": "XM_054356420.1"}, {"protein": "XP_054212394.1", "rna": "XM_054356419.1"}]}, "reporter": {"HG-U133_Plus_2": "206214_at", "HG-U95Av2": "37068_at", "HTA-2_0": "TC06001773.hg.1", "HuEx-1_0": "2955827", "HuGene-1_1": "8126784", "HuGene-2_1": "17019728"}, "summary": "The protein encoded by this gene is a secreted enzyme that catalyzes the degradation of platelet-activating factor to biologically inactive products. Defects in this gene are a cause of platelet-activating factor acetylhydrolase deficiency. Two transcript variants encoding the same protein have been found for this gene.[provided by RefSeq, Dec 2009].", "symbol": "PLA2G7", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1418625"}, "unigene": "Hs.584823", "uniprot": {"Swiss-Prot": "Q13093"}, "wikipedia": {"url_stub": "Lipoprotein-associated phospholipase A2"}}